230 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (57)
- Allergy, Asthma, & Immunology (1)
- All of Us Research Program - NIH (1)
- Autoimmune Disorders (5)
- Bone & Muscle (1)
- Cancer (9)
- COVID-19 (Coronavirus) (2)
- Diabetes (1)
- Gastrointestinal and Digestive Diseases (1)
- Hair and Skin Disorders (3)
- Healthy Volunteers (11)
- Heart Disease (3)
- Infectious Disease (1)
- Kidney Disease (1)
- Lung Disease (5)
- Neurological Disorders (3)
- Obstetrics & Gynecology (2)
- Pediatrics (3)
- Psychiatric Disorders (1)
- Rehabilitation (1)
- Transplant (1)
- Vascular Conditions (1)
Displaying 1 - 2 of 2
Condition: Cancer / Solid Tumors
Investigator: June Hou, MD
Status: Closed
The study drug (TSR-042) in this study is designed to stop cancer from growing by helping your immune system recognize and fight the cancer. The Study Drug is designed to help your immune system by attaching to a protein called PD-1 and stopping one of the signals that keeps your immune system from recognizing the cancer. This may help your immune system…
Condition: Neurological Disorders / Neuropathy
Investigator: Thomas Brannagan, MD
Status: Closed
The purpose of this study is to see how effective two doses of an investigational new drug called IgPro20 is when given subcutaneously (a shot given into the fat layer between the skin and the muscle) to treat CIDP in patients that still require IVIG and also to look at how safe the IgPro20 is for patients.